Bausch Health Companies BHC
NYSE BHC
$6.06 -0.10 (-1.62%)
As of: Sep 10, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Assets (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Assets came in at $24.8 billion in Q2 2026, down 9.07% year-over-year from $27.3 billion in Q2 2025, and up 1.21% quarter-over-quarter from $24.5 billion in Q1 2026.

Analysis

Bausch Health Companies (BHC) Assets (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Assets across 18 years of filings, most recently posting $24.8 billion for Q2 2026.

  • In Q2 2026, Assets fell 9.07% year-over-year to $24.8 billion; the TTM figure through Jun 2026 stood at $24.8 billion (down 9.07% YoY), while the FY2025 annual figure was $26.4 billion, down 0.59% from the prior year.
  • Assets came in at $24.8 billion for Q2 2026 at Bausch Health Companies, up from $24.5 billion in the prior quarter.
  • In the past five years, Assets ranged from a high of $29.1 billion in Q1 2022 to a low of $24.5 billion in Q1 2026.
  • Average Assets over 5 years is $26.5 billion, with a median of $26.5 billion recorded in 2024.
  • The largest YoY upside for Assets was 6.48% in 2023 against a maximum downside of 12.53% in 2023.
  • Over 5 years, Assets stood at $25.7 billion in 2022, then climbed by 6.48% to $27.4 billion in 2023, then slipped by 3.02% to $26.5 billion in 2024, then retreated by 0.59% to $26.4 billion in 2025, then dropped by 5.96% to $24.8 billion in 2026.
  • Per Business Quant data, the three most recent Assets figures were $24.8 billion in Q2 2026, $24.5 billion in Q1 2026, and $26.4 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Teva Pharmaceutical Industries 42.33 Bn 38.68 Bn 2.15 Bn 39.86 Bn
2 Viatris 19.05 Bn 18.16 Bn 1.46 Bn 35.04 Bn
3 Dr Reddys Laboratories 9.76 Bn 9.58 Bn 396.53 Mn 6.08 Bn
4 Amneal Pharmaceuticals 5.38 Bn 5.25 Bn 334.51 Mn 3.78 Bn
5 Bausch Health Companies 2.27 Bn 436.38 Mn 2.10 Bn 24.79 Bn
6 Alvotech 1.51 Bn 1.37 Bn 2.56 Mn 1.59 Bn
7 Ani Pharmaceuticals 1.51 Bn 1.15 Bn 165.89 Mn 1.49 Bn
8 Amphastar Pharmaceuticals 1.03 Bn 737.26 Mn 93.47 Mn 1.74 Bn
9 Fennec Pharmaceuticals 393.12 Mn 351.87 Mn 17.15 Mn 75.75 Mn
10 RedHill Biopharma 171.02 Mn 171.02 Mn - 25.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.79 Bn
Mar 31, 2026 24.50 Bn
Dec 31, 2025 26.37 Bn
Sep 30, 2025 26.82 Bn
Jun 30, 2025 27.27 Bn
Mar 31, 2025 26.42 Bn
Dec 31, 2024 26.52 Bn
Sep 30, 2024 26.54 Bn
Jun 30, 2024 26.50 Bn
Mar 31, 2024 26.91 Bn
Dec 31, 2023 27.35 Bn
Sep 30, 2023 27.06 Bn
Jun 30, 2023 25.50 Bn
Mar 31, 2023 25.45 Bn
Dec 31, 2022 25.69 Bn
Sep 30, 2022 26.30 Bn
Jun 30, 2022 28.17 Bn
Mar 31, 2022 29.09 Bn
Dec 31, 2021 29.20 Bn
Sep 30, 2021 29.25 Bn